Ceri Wiggins is currently the Director of Phenotypic Screening at AstraZeneca, a position held since 2021. Wiggins previously served as a Senior Scientist and Manager at Horizon Discovery from 2011 to 2014, and prior to that was a Post Doctoral Research Fellow at NIMR from 2009 to 2011. Wiggins earned a PhD from the University of Cambridge from 2005 to 2009 and holds a BSc in Biochemistry from the University of Warwick, completed in 2005.
This person is not in the org chart
This person is not in any teams
This person is not in any offices